Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Cancer Monthly is reporting on a recently-published meta-analysis of diabetes patients that appears to show no increased risk of bladder cancer as a result of using human insulin.
The large-scale study analyzed the health insurance reimbursement databases of 785,234 type 2 diabetes patients from 1996 to 2009. In 2009, the entire database was examined for cases of bladder cancer. To ensure that the study data was not impacted by other potential bladder cancer risks, the study excluded patients on pioglitazone (Actos), which has been shown to increase the risk of bladder cancer in diabetics. Patients on a human insulin analog called insulin glargine were also excluded.
http://www.prweb.com/releases/2014/02/prweb11570747.htm
The large-scale study analyzed the health insurance reimbursement databases of 785,234 type 2 diabetes patients from 1996 to 2009. In 2009, the entire database was examined for cases of bladder cancer. To ensure that the study data was not impacted by other potential bladder cancer risks, the study excluded patients on pioglitazone (Actos), which has been shown to increase the risk of bladder cancer in diabetics. Patients on a human insulin analog called insulin glargine were also excluded.
http://www.prweb.com/releases/2014/02/prweb11570747.htm